Eyram Ahadzi

Eyram Ahadzi

Auto-generated profile, based on publicly available information

Eyram Ahadzi

Department of Computer Engineering College of Engineering Kwame Nkrumah University of Science and Technology Kumasi 00233 Ghana knust.edu.gh

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in International Journal of Biomaterials
Verified
Journal Article
Open access
EAEyram Ahadzi
Eyram Ahadzi
OMOtema Darfour Manu
Otema Darfour Manu
RARUTH ANTWIBAAH
RUTH ANTWIBAAH
HAHenry Agbe
Henry Agbe
PAPrince Ebenezer Adjei
Prince Ebenezer Adjei
Smart hydrogels are stimuli‐responsive biomaterials that enable targeted, sustained, and controlled therapeutic delivery. Their unique ability to respond to physiological cues such as pH, temperature, reactive oxygen species (ROS), and enzymatic activity makes them highly attractive for myocardial infarction (MI) therapy. This scoping review explores advances, applications, challenges, and future perspectives related to the use of smart hydrogels in MI. An initial comprehensive search of PubMed, Scopus, and ScienceDirect yielded 1802 records, from which 32 studies published between 2011 and 2025 met the inclusion criteria under the PRISMA‐ScR framework. An updated search identified seven additional eligible studies, bringing the total to 39 included studies. These studies primarily focused on smart hydrogels for delivering bioactive agents, including growth factors, stem cells, exosomes, and nanoparticles, to enhance myocardial regeneration and repair. Evidence from preclinical models consistently demonstrated improvements in myocardial remodeling, angiogenesis, cell survival, and functional cardiac recovery. Despite these encouraging findings, several important limitations were identified. Studies relied on short evaluation periods, lacked long‐term follow‐up, and were restricted to small‐animal models, thereby limiting the robustness of translational insights. Large‐animal studies and early clinical investigations remain scarce, highlighting the gap between experimental progress and clinical application. Nonetheless, smart hydrogels stand out as a promising therapeutic platform because of their capacity for localized, adaptive, and sustained responses within the complex postinfarct microenvironment. Future work should prioritize long‐term efficacy studies, development of minimally invasive delivery methods, and the use of clinically relevant preclinical models to better facilitate translation to human MI therapy.

7 February 2026 in Journal of Biomedical Engineering Systems and Technologies for LMICs
Verified
Journal Article
Open access
EAEyram Ahadzi
Eyram Ahadzi
SHSheriff-Deen Hasmin
Sheriff-Deen Hasmin
IAIsaac Acquah
Isaac Acquah
PAPrince Ebenezer Adjei
Prince Ebenezer Adjei
Cardiovascular diseases (CVDs) are the leading cause of death globally, with low- and middle-income countries (LMICs) bearing the greatest burden. Electrocardiograms (ECGs), which reflect the heart's electrical activity, are an essential tool in diagnosing CVD. The QRS complex is the most prominent wave in an ECG signal and is used for evaluating the overall heart function of an individual. The Pan-Tompkins algorithm is widely used for the detection of QRS complexes. It is, however, susceptible to baseline wander noise, has decreased sensitivity for diverse ECG morphologies, and exhibits real-time delay, leading to its suboptimal performance in QRS complex detection. This study presents an improved PanTompkins approach that combines the strengths of the Pan-Tompkins algorithm with a Recurrent Neural Network (RNN) to deliver more accurate and efficient QRS detection. The proposed algorithm achieved precision, recall, and F1-scores above 96% on Lead II of the MIT-BIH Arrhythmia Database. Overall, false positive and false negative rates were below 0.05%, calculated across the selected segments from all patient records. Execution time was reduced by 4% relative to the original Pan–Tompkins algorithm on identical ECG segments, directly lowering latency and improving real-time performance. A band-pass filter of 6–16 Hz was used, which improved robustness against baseline wander, effectively reducing noise. The algorithm demonstrated enhanced resilience to morphological variability in ECG signals, ensuring more reliable detection across diverse patterns. By integrating this AI-driven algorithm into low-cost, portable ECG devices, there is strong potential to support early detection of CVDs, particularly in underserved areas. This work contributes to a practical, scalable solution that can help strengthen digital health infrastructure and improve clinical outcomes in LMICs.